DuoResp Spiromax

Medicinal product

(Invented) name

DuoResp Spiromax

Active substance (s)

Budezonidas/Formoterolio fumaratas dihidratas

Strength

320 µg/9 µg

Pharmaceutical form

įkvepiamieji milteliai

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03AK07, Formoterol and budesonide

Marketing authorisation holder

TEVA Pharma B.V., Nyderlandai

Date of authorisation

2014-04-28

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Inhalation powder	1 dozėje
Budezonidas	320 µg
Formoterolio fumaratas dihidratas	9 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
59070	73291	1073291	inhaliatorius	60 dozių N1		Receptinis	EU/1/14/920/004	Tiekiama	-	-	No	-	-
59071	73292	1073292	inhaliatorius	60 dozių N2 (2×60 dozių)		Receptinis	EU/1/14/920/005	Netiekiama	-	-	No	-	-
59072	73293	1073293	inhaliatorius	60 dozių N3 (3×60 dozių)		Receptinis	EU/1/14/920/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-04-28	Registruotas